Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
- PMID: 19898647
- PMCID: PMC2773751
- DOI: 10.2147/tcrm.s3101
Antimicrobial prophylaxis in colorectal surgery: focus on ertapenem
Abstract
Despite improvement in infection control measures and surgical practice, surgical site infections (SSIs) remain a major cause of morbidity and mortality. In colorectal surgery, perioperative administration of a suitable antimicrobial regimen that covers both anaerobic and aerobic bacteria is universally accepted. In a prospective, double-blind, randomized study ertapenem was recently found to be more effective than cefotetan, a parenteral cephalosporin so broadly used as to be considered as gold standard in the prevention of SSIs following colorectal surgery. In this adequate and well controlled study, the superiority of ertapenem over cefotetan was clearly demonstrated from the clinical and bacteriological points of view. However, data that directly compares ertapenem with other antimicrobial regimen effective in preventing SSIs following colorectal surgery are lacking; furthermore, the possible risk of promotion of carbapenem resistance associated with widespread use of ertapenem prophylaxis as well as the ertapenem effects on the intestinal gut flora are of concern. Further comparative studies of ertapenem versus other widely used prophylactic regimens for colorectal surgery in patients submitted to mechanical bowel preparation versus no preparation as well as further research on adverse events of antibiotic prophylaxis, including emergence of resistance and Clostridium difficile infection, seem warranted.
Keywords: colorectal surgery; ertapenem; surgical prophylaxis.
Similar articles
-
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery.N Engl J Med. 2006 Dec 21;355(25):2640-51. doi: 10.1056/NEJMoa054408. N Engl J Med. 2006. PMID: 17182989 Clinical Trial.
-
Effect of body mass index and ertapenem versus cefotetan prophylaxis on surgical site infection in elective colorectal surgery.Surg Infect (Larchmt). 2008 Apr;9(2):131-7. doi: 10.1089/sur.2007.034. Surg Infect (Larchmt). 2008. PMID: 18426345 Clinical Trial.
-
Infection after elective colorectal surgery: bacteriological analysis of failures in a randomized trial of cefotetan vs. ertapenem prophylaxis.Surg Infect (Larchmt). 2009 Apr;10(2):111-8. doi: 10.1089/sur.2007.096. Surg Infect (Larchmt). 2009. PMID: 19226203 Clinical Trial.
-
Is Single-Dose Antimicrobial Prophylaxis Sufficient to Control Infections in Gastrointestinal Oncological Surgeries?Cureus. 2021 Aug 6;13(8):e16939. doi: 10.7759/cureus.16939. eCollection 2021 Aug. Cureus. 2021. PMID: 34513508 Free PMC article. Review.
-
The Role of Antibiotic Prophylaxis in Anastomotic Leak Prevention during Elective Colorectal Surgery: Systematic Review and Meta-Analysis of Randomized Controlled Trials.Antibiotics (Basel). 2023 Feb 16;12(2):397. doi: 10.3390/antibiotics12020397. Antibiotics (Basel). 2023. PMID: 36830306 Free PMC article. Review.
Cited by
-
Serum in vivo and in vitro activity of single dose of ertapenem in surgical obese patients for prevention of SSIs.Obes Surg. 2013 Jul;23(7):911-9. doi: 10.1007/s11695-013-0879-1. Obes Surg. 2013. PMID: 23504617
-
Pharmacokinetic differences between the epimers of cefotetan disodium after single intravenous injection in healthy Chinese volunteers.Eur J Drug Metab Pharmacokinet. 2011 Dec;36(4):223-8. doi: 10.1007/s13318-011-0064-7. Epub 2011 Sep 14. Eur J Drug Metab Pharmacokinet. 2011. PMID: 21915733 Clinical Trial.
-
Antimicrobial prophylaxis for colorectal surgery.Cochrane Database Syst Rev. 2014 May 9;2014(5):CD001181. doi: 10.1002/14651858.CD001181.pub4. Cochrane Database Syst Rev. 2014. PMID: 24817514 Free PMC article. Review.
References
-
- Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol. 1999;20:250–278. - PubMed
-
- Dimick JB, Chen SI, Taheri PA, Henderson WG, Khuri SF, Campbell DA., Jr Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program. J Am Coll Surg. 2004;199:531–537. - PubMed
-
- Dimick JB, Pronovost PJ, Cowan JA, Lipsett PA. Complications and costs after high-risk surgery: where should we focus quality improvement initiatives? J Am Coll Surg. 2003;196:671–678. - PubMed
-
- Zhan C, Miller MR. Excess length of stay, charges and mortality attributable to medical injures during hospitalization. JAMA. 2003;290:1868–1874. - PubMed
LinkOut - more resources
Full Text Sources